There are 2789 resources available
1265P - Combined detection of tumor markers and ctDNA in cerebrospinal fluid: A good strategy in diagnosis of leptomeningeal metastases
Presenter: Yong Wang
Session: ePoster Display
1266P - Genetic profiling of cell-free DNA from pleural effusion in advanced lung cancer as a surrogate for tumor tissue and revealed additional clinical actionable targets
Presenter: Hai-Yan Tu
Session: ePoster Display
1267P - Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy
Presenter: Mariona Riudavets Melia
Session: ePoster Display
1268P - Real-time clinical utility of ctDNA genomic alterations in untreated patients with advanced NSCLC
Presenter: Marta Garcia De Herreros
Session: ePoster Display
1269P - Identification of rare gene fusions in non-small cell lung cancer with next-generation sequencing
Presenter: Minglei Zhuo
Session: ePoster Display
Resources:
Abstract
1270P - Genomic alterations of bone metastases in stage IV non-small cell lung cancer (NSCLC) and real-world outcomes
Presenter: Pei Jye Voon
Session: ePoster Display
1271P - Molecular driver mutations in never-smokers with lung adenocarcinoma
Presenter: Philip Mack
Session: ePoster Display
1272P - First results of the early onset lung cancer (EOLUNG) study to characterize genomic alterations using FoundationOne CDx in young patients with non-small cell lung cancer
Presenter: Maria Jove Casulleras
Session: ePoster Display
1273P - Sputum supernatant as a viable liquid biopsy in advanced non-small cell lung cancer
Presenter: Chengzhi Zhou
Session: ePoster Display
1274P - An audit of liquid biopsies for NSCLC patients over a 50-month period in a resource constrained setting
Presenter: Navneet Singh
Session: ePoster Display